Organon Says Nduvra Cream Gets Canada Approval for Atopic Dermatitis

MT newswire2026/09/28 13:24

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

09:24 AM EDT, 09/28/2026 (MT Newswires) -- Organon (OGN) subsidiary Organon Canada said Monday it has received approval for Nduvra tapinarof cream 1% to treat moderate to severe atopic dermatitis in adults and children at least two years old. Nduvra is a steroid-free topical treatment and the new indication marks the second approval for the cream in Canada, Organon Canada said.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Organon Says Nduvra Cream Gets Canada Approval for Atopic Dermatitis

You may also like

Crypto prices